Skin Cancer: Drug Gives ‘40% Melanoma Survival’

According to a new article via BBC.com, “Four-in-10 patients with a deadly skin cancer were still alive after three years when given a drug to boost their immune system, a study suggests.  The trial gave 655 patients with melanoma the drug Pembrolizumab, which...